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Purpose:  In order to identify methods for preventing phlebitis caused by intravenous administration of vi-
norelbine (VNR), we established a procedure for estimating the severity of phlebitis in an animal model. 
Methods: Four different factors (administration rate, dilution, flushing, and infusion of fat emulsion) were 
evaluated for alleviation of phlebitis caused by VNR infusion. VNR was diluted with normal saline to prepare test 
solutions with concentrations of 0.6 mg/mL or 0.3 mg/mL for infusion into the auricular veins of rabbits. Two 
days after VNR infusion, the veins were subjected to histopathological examination. 
Results: VNR did not cause obvious loss of venous endothelial cells, the most sensitive and common feature of 
phlebitis, but VNR infusion led to inflammatory cell infiltration, edema, and epidermal degeneration. 
Tissue damage was significantly decreased by shortening the administration time and by diluting the VNR solu-
tion for infusion from 0.6 mg/mL to 0.3 mg/mL. However, there was no effect of flushing with normal saline after 
VNR infusion, while treatment with fat emulsion before and after VNR infusion only had a minimal effect. 
Conclusion: Rapid infusion and dilution are effective methods of reducing phlebitis caused by the infusion of 
VNR, but the efficacy of flushing with normal saline or infusion of fat emulsion was not confirmed. 
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1.  Introduction 
Vinorelbine (VNR) is a semi-synthetic vinca al-
kaloid derived from vinblastine that is used to treat 
non-small cell lung cancer (NSCLC) and breast cancer. 
For the treatment of NSCLC, VNR is administered at a 
dose of 20 to 25 mg/m 2 alone [1] or in combination 
with cisplatin [2] or gemcitabine [3, 4]. VNR is also 
administered at a dose of 25 mg/m2 alone or com-
bined with cisplatin or trastuzumab in patients with 
inoperable, advanced, and recurrent breast cancer, 
who have previously received anthracyclines and 
taxanes [5, 6]. The main adverse effects of VNR are 
granulocytopenia, leucopenia, and thrombocytopenia, 
with granulocytopenia being the primary 
dose-limiting toxicity. Phlebitis is another problematic 
adverse effect of intravenous VNR, and the incidence 
of phlebitis (local venous toxicity) after a 6-min infu-
sion of VNR has been reported as 16-33% [7-9]. Phlebi-
tis limits the continuation of chemotherapy by de-
creasing patient motivation and compliance. 
VNR has been reported to cause venous discol-
oration and chemical phlebitis proximal to the site of 
injection, as well as localized rashes and urticaria, 
blistering, and skin sloughing [10]. It is a vesicant and 
venous irritant like other vinca alkaloids. Factors that 
influence the development of phlebitis include the 
quality of the vein selected, the size and type of cathe-
ter used, the duration of infusion, and the pH and Int. J. Med. Sci. 2008, 5 
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osmolality of the drug solution. The Japanese package 
insert for VNR recommends dilution with 50 mL of 
normal saline or 5% glucose and administration over 
less than 10 min, followed by flushing of the vein but 
the effectiveness of this protocol has not been evalu-
ated. 
The purpose of the present study was to establish 
an experimental method for estimating the severity of 
phlebitis caused by VNR in rabbits, and then to test 
various methods that have been reported for prevent-
ing phlebitis caused by intravenous VNR, including 
more rapid administration, dilution, flushing, and in-
fusion of fat emulsion [11-13]. 
2.  Materials and Methods 
Animals 
Male Japanese white rabbits (Std; JW, Japan SLC, 
Inc., Shizuoka, Japan) weighing between 2.3 and 3.5 
kg were housed in individual cages in an animal room 
maintained at 23 ± 3°C and 55 ± 10 % relative humid-
ity with ventilation 13-16 times/hr and a 12-hr 
light-dark cycle. The rabbits were allowed free access 
to diet and water, except during treatment. This study 
was approved by the Committee on Animal Experi-
ments of Mukogawa Women’s University. 
Drugs 
Navelbine® Injection (VNR) was kindly provided 
by Kyowa Hakko Kogyo Co. (Tokyo, Japan). A 1- mL 
vial of Navelbine® Injection was diluted with normal 
saline (Otsuka Normal Saline; Otsuka Pharmaceutical 
Factory, Inc., Tokushima, Japan) to provide either a 0.6 
mg/mL or 0.3 mg/mL solution of VNR. In addition, 
normal saline and 20% fat emulsion (Intralipos® 20%: 
Otsuka Pharmaceutical Factory, Inc.) were tested to 
examine their influence on VNR-induced phlebitis. 
Experimental procedure 
Test solutions were infused through a plastic 
catheter (Surflo, 24 gauge, outer diameter of 0.67 mm 
and length of 19 mm; Terumo Co., Tokyo, Japan) into 
an ear vein using a peristaltic pump (Minipuls 2, Gil-
son, Inc., WI, USA) (Figure 1). Veins in both ears were 
employed to compare different infusion conditions. 
The dose of VNR was set at 1.5 mg/kg in all experi-
ments. Rabbits were killed by an overdose of sodium 
pentobarbital (Nembutal®, Dainippon Sumitomo 
Pharmaceutical Co., Osaka, Japan) at 2 days after infu-
sion. Two samples of the ear vein were obtained, in-
cluding the region 3-10 mm from the catheter tip 
(proximal region) and the region 20-30 mm from the 
catheter tip (distal region) (Figure 1). These were fixed 
in phosphate-buffered saline containing 10% formalin. 
Then cross-sections of the ear vein were prepared and 
stained with hematoxylin and eosin (HE). Histopa-
thological examination was performed blindly, with 
the findings being graded according to the criteria 
shown in Table 1. These criteria were based on those 
of Kuwahara [14], with the addition of epidermal de-
generation. 
 
Figure 1. Sites of histopathological examination. Two regions 
of the ear vein, one located 3-10 mm from the catheter tip 
(proximal region) and the other located 20-30 mm (distal re-
gion) from it, were sampled at 2 days after infusion. 
Table 1 Criteria for histopathological examination 
 
Influence of the infusion rate 
In 8 rabbits, a 0.6 mg/mL solution of VNR was 
infused into one ear vein for 30 min at 5 mL/kg/hr as 
a control, and the same solution was infused into the 
contralateral ear vein for 10 min at 15 mL/kg/hr 
(3-fold faster). The concentration of VNR was selected 
to be similar to the clinical concentration range. Before Int. J. Med. Sci. 2008, 5 
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and after VNR infusion, normal saline was infused 
into both veins for 24 min at 5 mL/kg/hr. 
Influence of the concentration 
In 8 rabbits, a 0.6 mg/mL solution of VNR was 
infused into one ear vein for 30 min at 5 mL/kg/hr as 
a control, and a 0.3 mg/mL solution of VNR was in-
fused into the contralateral ear vein for 30 min at 10 
mL/kg/hr. 
Effect of flushing with normal saline 
A 0.6 mg/mL solution of VNR was infused for 30 
min at 5 mL/kg/hr into the right and left ear veins of 
8 rabbits. In one ear vein, infusion of VNR was fol-
lowed by flushing with 5 mL of normal saline for 1 
min, while the other ear vein was not flushed as a 
control. 
Effect of 20% fat emulsion 
A 0.6 mg/mL solution of VNR was infused for 30 
min at 5 mL/kg/hr into the right and left ear veins of 
8 rabbits. In one ear vein, 20% fat emulsion (Intrali-
pos®) was infused for 24 min at 5 mL/kg/hr both be-
fore and after VNR infusion. In the other ear vein, 
normal saline was infused in the same manner as a 
control. 
Statistical analysis 
The grade of each histopathological finding was 
compared between groups by the Wilcoxon rank sum 
test and p<0.05 was considered to indicate a signifi-
cant difference. 
3.  Results 
Influence of the infusion rate 
Figure 2 shows a representative photomicro-
graph of a normal vein without exposure to VNR and 
Table 2 summarizes the histopathological findings 
after infusion of VNR at a normal or rapid rate. Infu-
sion of a 0.6 mg/mL solution of VNR for 30 min at 5 
mL/kg/hr (control) only caused slight loss of venous 
endothelial cells (Grade 1) in the distal region of the 
vein in 1 of 8 animals. In addition, there was inflam-
matory cell infiltration (Grades 2-3) in the proximal 
and distal regions of the vein in 5 animals each, edema 
(Grades 1-2) of the proximal vein region in 3 animals 
and the distal region in 5 animals, and epidermal de-
generation (Grades 1-3) at both the proximal and dis-
tal regions in all 8 animals (Figure 3). After infusion of 
the same solution 3 times more rapidly (10 min, 15 
mL/kg/hr), there was inflammatory cell infiltration 
(Grades 1-2) at the proximal vein region in 4 out of 8 
animals and at the distal region in 3 animals, but 
edema (Grade 2) was only found in the proximal re-
gion of 1 animal. Epidermal degeneration (Grades 1-3) 
still occurred at both the proximal and distal regions 
in 7 out of 8 animals. Edema of the distal region was 
significantly less severe in the rapid infusion group 
compared with the control infusion group (p<0.05). 
 
Figure 2. Typical photomicrographs of an untreated ear vein. 
 
Figure 3. Typical photomicrographs of an ear vein after VNR 
infusion. A 0.6-mg/mL solution of VNR was infused into an ear 
vein for 30 min at 5 mL/kg/hr, and the vein was subjected to 
pathological examination after 2 days. Int. J. Med. Sci. 2008, 5 
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Table 2 Influence of the infusion rate on histopathological changes at 2 days after VNR infusion. In 8 rabbits, a 0.6-mg/mL solution 
of VNR was infused into one ear vein for 30 min at 5 mL/kg/hr as a control, and the same solution was also infused into the con-
tralateral ear vein for 10 min at 15 mL/kg/hr (3-fold faster). 












  Grade  0 1 2 3   0 1 2 3   0 1 2 3   0 1 2 3  
Control  8 0 0 0  3 0 2 3  5 2 1 0  0 2 3 3  Proximal 
Rapid  8 0 0 0 
N.S. 
4 3 1 0 
N.S. 
7 0 1 0 
N.S. 
1 2 4 1 
N.S. 
Control  7 1 0 0  3 0 3 2  3 3 2 0  0 3 2 3  Distal 
Rapid  8 0 0 0 
N.S. 
5 1 2 0 
N.S. 
8 0 0 0 
<0.05 
1 3 4 0 
N.S. 
Numbers in the table represent the number of observations. N.S.; not significant 
 
Influence of the concentration 
The results of histopathological examination are 
shown in Table 3. Infusion of a 0.6 mg/mL solution of 
VNR (control solution) caused slight loss of venous 
endothelial cells (Grade 1) at the proximal vein region 
in 2 out of 8 animals and at the distal region in 3 ani-
mals, as well as inflammatory cell infiltration (Grades 
1-2) in the proximal region of all 8 animals and the 
distal region of 7 animals. In addition, edema (Grades 
1-3) was noted at the proximal region in 4 animals and 
at the distal region in 5 animals, while epidermal de-
generation (Grades 2-3) was seen at both the proximal 
and distal regions in all 8 animals. The 0.3 mg/mL 
solution of VNR (diluted solution) caused slight loss 
of venous endothelial cells (Grade 1) at the proximal 
vein region in 3 out of 8 animals and at the distal re-
gion in 2 animals, inflammatory cell infiltration 
(Grades 1-3) in the proximal and distal regions of 6 
animals, edema (Grade 2) at the proximal region in 1 
animal and the distal region in 3 animals, and epi-
dermal degeneration (Grades 1-3) at both the proximal 
and distal regions in all 8 animals. Significantly less 
severe epidermal degeneration at the proximal region 
was noted after infusion of the diluted solution 
(p<0.05). 
Effect of flushing with normal saline 
Table 4 shows a comparison of the histopa-
thological grades between VNR infusion with and 
without a normal saline flush. Flushing with normal 
saline led to a slight reduction in the loss of venous 
endothelial cells, but the improvement was not statis-
tically significant. 
Effect of 20% fat emulsion 
The results of histopathological examinations are 
shown in Table 5. No significant differences were ob-
served after infusion of fat emulsion. 
Table 3 Influence of the concentration on histopathological changes at 2 days after VNR infusion. In 8 rabbits, a 0.6-mg/mL solution 
of VNR was infused into one ear vein for 30 min at 5 mL/kg/hr as a control, and a 0.3-mg/mL solution of VNR was infused into the 
contralateral ear vein for 30 min at 10 mL/kg/hr. 













  Grade  0 1 2 3   0 1 2 3   0 1 2 3   0 1 2 3  
Control  6 2 0 0  0 2 6 0  4 2 2 0  0 0 5 3  Proximal 
Dilution  5 3 0 0 
N.S. 
2 3 3 0 
N.S. 
7 0 1 0 
N.S. 
0 2 6 0 
<0.05 
Control  5 3 0 0  1 1 6 0  3 1 3 1  0 0 5 3  Distal 
Dilution  6 2 0 0 
N.S. 
2 3 2 1 
N.S. 
5 0 3 0 
N.S. 
0 2 5 1 
N.S. 
Numbers in the table represent the number of observations. N.S.; not significant 
Table 4 Effect of flushing with normal saline on histopathological changes at 2 days after VNR infusion. A 0.6-mg/mL solution of 
VNR was infused for 30 min at 5 mL/kg/hr into the right and left ear veins of 8 rabbits. In one ear vein, VNR infusion was followed 
by flushing with normal saline (5 mL over 1 min), while the other ear vein was not flushed as a control. 














  Grade  0 1 2 3   0 1 2 3   0 1 2 3   0 1 2 3  
Without  flush  4 4 0 0  1 3 4 0  1 6 1 0  0 0 4 4  Proximal 
With  flush  7 1 0 0 
N.S. 
1 0 5 2 
N.S. 
3 1 3 1 
N.S. 
0 0 4 4 
N.S. 
Without  flush  6 2 0 0  1 1 6 0  2 2 4 0  0 0 6 2  Distal 
With  flush  7 1 0 0 
N.S. 
2 1 4 1 
N.S. 
3 1 3 1 
N.S. 
0 1 4 3 
N.S. 
Numbers in the table represent the number of observations. N.S.; not significant   Int. J. Med. Sci. 2008, 5 
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Table 5 Effect of fat emulsion on histopathological changes at 2 days after VNR infusion. A 0.6-mg/mL solution of VNR was 
infused for 30 min at 5 mL/kg/hr into the right and left ear veins of 8 rabbits. In one ear vein, 20% fat emulsion (Intralipos
®) was 
infused for 24 min at 5 mL/kg/hr before and after VNR infusion. In the other ear vein, normal saline was infused in the same manner 
as a control. 














  Grade  0 1 2 3   0 1 2 3   0 1 2 3   0 1 2 3  
Without  treatment  8 0 0 0  2 0 4 2  4 3 1 0  0 0 7 1  Proximal 
With  treatment  8 0 0 0 
N.S. 
1 4 3 0 
N.S. 
4 3 1 0 
N.S. 
0 2 4 2 
N.S. 
Without  treatment  8 0 0 0  1 3 3 1  4 2 2 0  0 1 6 1  Distal 
With  treatment  8 0 0 0 
N.S. 
2 3 3 0 
N.S. 
3 4 1 0 
N.S. 
0 3 5 0 
N.S. 
Numbers in the table represent the number of observations. N.S.; not significant   
 
4.  Discussion 
VNR is widely used to treat solid tumors such as 
NSCLC [1-4] and breast cancer [5, 6]. Phlebitis due to 
infusion of VNR is the one of the complications that 
limits treatment. Various methods of avoiding such 
phlebitis have been reported [11-13], but none are 
completely effective. It was reported that rapid infu-
sion and flushing are effective for reducing phlebitis 
in the clinical setting [7], so an infusion rate of less 
than 5 minutes [15] but more than 1 minute has been 
recommended for VNR [7]. To clarify the most effi-
cient methods of preventing VNR induced phlebitis, 
we evaluated the effects of the VNR infusion rate, 
VNR concentration, saline flushing, and infusion of fat 
emulsion on phlebitis in a rabbit auricular vein model. 
There is little histopathological information 
about the effects of VNR infusion in animals and hu-
mans. However, infusion into the auricular vein in 
rabbits has been often used to investigate phlebitis 
[16-18]. In addition, we have already investigated the 
influence of osmolarity on phlebitis in this model [19], 
and the results were consistent with clinical data re-
ported by Kerin and colleagues [20]. Thus, it was 
thought that this model could be used to investigate 
phlebitis caused by the infusion of VNR. 
Infusion of VNR did not cause marked loss of 
venous endothelial cells, which is considered to be the 
most sensitive and common feature of phlebitis due to 
experimental infusion [16], but it caused epidermal 
degeneration in almost all cases (Table 3). These find-
ings suggested that VNR has different characteristics 
from common chemical irritants that induce phlebitis. 
Although the reason for this difference is unclear, it 
seems likely that part of a dose of VNR infused into a 
peripheral vein escapes into the perivascular tissue 
and reaches the epidermis, where it causes the 
changes of “epidermal degeneration.”   
It has been reported that infusion of VNR over 
6-10 minutes decreases the incidence of phlebitis 
compared with infusion over 20-30 minutes [9], and 
the frequency of phlebitis is even lower decreased 
with bolus administration over 1 min followed by 
flushing with normal saline [7]. We also found that 
tissue damage was decreased by a shorter infusion 
time, suggesting that this rabbit model was appropri-
ate to investigate VNR-related phlebitis. We con-
firmed that the infusion rate had an important influ-
ence on VNR-induced phlebitis. 
It has been suggested that dilution is effective for 
reducing phlebitis caused by various agents in hu-
mans and animals [21, 22]. In this study, we confirmed 
that dilution could alleviate VNR-induced phlebitis, 
suggesting that the drug concentration could one of 
the important factors provoking its occurrence. Thus, 
it is probably better to dilute VNR before infusion. 
Flushing with normal saline after VNR infusion and 
infusion of fat emulsion both before and after VNR 
were also investigated in this study. Although flush-
ing with normal saline led to a slight reduction in the 
loss of venous endothelial cells (Table 4), the effect 
was not significant. The manufacturer of VNR rec-
ommends flushing with >75-125 mL of fluid after in-
fusion [23], but there is little information about the 
efficacy of flushing. We did not confirm its usefulness 
in this study, so further investigation is needed. 
Matsusune et al. reported that infusion of fat 
emulsion reduced phlebitis in patients receiving pe-
ripheral parenteral nutrition, and suggested that it had 
a protective effect on the peripheral veins [24]. How-
ever, we did not observe any effect of fat emulsion on 
phlebitis caused by VNR, suggesting that its infusion 
might provide insufficient protection. 
Phlebitis is considered to be associated with the 
mechanism of action of VNR. Rapid infusion and di-
lution with normal saline were both effective for re-
ducing phlebitis after VNR infusion. That is, the de-
velopment of phlebitis was related to the amount of 
contact (infusion duration and solution concentration) 
between VNR and the vascular endothelium. Since 
greater blood flow allows a more rapid rate of ad-
ministration and more dilution VNR, choosing a large 
vessel with rapid blood flow may also be effective for 
preventing phlebitis caused by VNR infusion. Int. J. Med. Sci. 2008, 5 
 
223
In conclusion, our results suggest that rapid ad-
ministration and dilution of the infusion solution are 
effective methods for preventing VNR-induced phle-
bitis. Choosing a large vein might also have a preven-
tive effect, but further studies are needed for confir-
mation. 
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